Efficacy News and Research

RSS
Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

New antibody can improve quality of life for individuals with asthma

New antibody can improve quality of life for individuals with asthma

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Pemetrexed plus erlotinib shows benefits in NSCLC

Pemetrexed plus erlotinib shows benefits in NSCLC

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx announces financial results for Q1 2014, provides operational update

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Novel drug for patients with inoperable CTEPH shows improvement in international trial

Novel drug for patients with inoperable CTEPH shows improvement in international trial

Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

Juventas presents positive trial results of JVS-100 drug delivered by Biocardia’s Helix transendocardial system

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

Study compares effectiveness of duloxetine and fluoxetine in children with MDD

Study compares effectiveness of duloxetine and fluoxetine in children with MDD

Ring pessary for OAB as effective as nonsurgical therapies

Ring pessary for OAB as effective as nonsurgical therapies

CTR1 may be required for successful platinum-based therapy in NSCLC

CTR1 may be required for successful platinum-based therapy in NSCLC

Vandetanib delays disease progression in elderly NSCLC patients

Vandetanib delays disease progression in elderly NSCLC patients

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Researchers identify drugs to slow progression of idiopathic pulmonary fibrosis

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

Study examines predictors and effects of testosterone therapy

Study examines predictors and effects of testosterone therapy

FibroGen’s Phase 2a study supports safety and efficacy of FG-3019 in IPF patients

FibroGen’s Phase 2a study supports safety and efficacy of FG-3019 in IPF patients

Study shows technology improves transition into adulthood for adolescents with chronic disease

Study shows technology improves transition into adulthood for adolescents with chronic disease

IAVI: Together, we can achieve a world without AIDS

IAVI: Together, we can achieve a world without AIDS

Chronic bystander viral impairs development of memory T cells

Chronic bystander viral impairs development of memory T cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.